Focus on specialty drugs reflects ‘cyclical nature’ of biopharma, industry veteran says

Adam Schechter, an adviser to Merck's CEO, said at the Veeva Summit Tuesday that many primary care diseases - such as cardiovascular disease and Alzheimer's - still have significant unmet needs.